Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Non-Current Debt (2016)

Historic Non-Current Debt for Dare Bioscience (DARE) over the last 4 years, with Q4 2016 value amounting to $4.4 million.

  • Dare Bioscience's Non-Current Debt fell 6497.0% to $4.4 million in Q4 2016 from the same period last year, while for Dec 2016 it was $4.4 million, marking a year-over-year decrease of 6497.0%. This contributed to the annual value of $4.4 million for FY2016, which is 6497.0% down from last year.
  • As of Q4 2016, Dare Bioscience's Non-Current Debt stood at $4.4 million, which was down 6497.0% from $6.6 million recorded in Q3 2016.
  • Dare Bioscience's Non-Current Debt's 5-year high stood at $13.6 million during Q1 2015, with a 5-year trough of $587000.0 in Q3 2014.
  • For the 4-year period, Dare Bioscience's Non-Current Debt averaged around $7.2 million, with its median value being $7.6 million (2016).
  • Its Non-Current Debt has fluctuated over the past 5 years, first surged by 169386.71% in 2015, then crashed by 6497.0% in 2016.
  • Over the past 4 years, Dare Bioscience's Non-Current Debt (Quarter) stood at $3.1 million in 2013, then crashed by 81.21% to $587000.0 in 2014, then skyrocketed by 2058.77% to $12.7 million in 2015, then crashed by 64.97% to $4.4 million in 2016.
  • Its last three reported values are $4.4 million in Q4 2016, $6.6 million for Q3 2016, and $8.6 million during Q2 2016.